359 related articles for article (PubMed ID: 19472238)
21. The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility.
Saupe SJ
Semin Cell Dev Biol; 2011 Jul; 22(5):460-8. PubMed ID: 21334447
[TBL] [Abstract][Full Text] [Related]
22. Correlation of structural elements and infectivity of the HET-s prion.
Ritter C; Maddelein ML; Siemer AB; Lührs T; Ernst M; Meier BH; Saupe SJ; Riek R
Nature; 2005 Jun; 435(7043):844-8. PubMed ID: 15944710
[TBL] [Abstract][Full Text] [Related]
23. On the binding of Thioflavin-T to HET-s amyloid fibrils assembled at pH 2.
Sabaté R; Lascu I; Saupe SJ
J Struct Biol; 2008 Jun; 162(3):387-96. PubMed ID: 18406172
[TBL] [Abstract][Full Text] [Related]
24. Probing the structure of the infectious amyloid form of the prion-forming domain of HET-s using high resolution hydrogen/deuterium exchange monitored by mass spectrometry.
Nazabal A; Maddelein ML; Bonneu M; Saupe SJ; Schmitter JM
J Biol Chem; 2005 Apr; 280(14):13220-8. PubMed ID: 15647259
[TBL] [Abstract][Full Text] [Related]
25. A novel in vitro filter trap assay identifies tannic acid as an amyloid aggregation inducer for HET-s.
Boyé-Harnasch M; Cullin C
J Biotechnol; 2006 Sep; 125(2):222-30. PubMed ID: 16621084
[TBL] [Abstract][Full Text] [Related]
26. Solid-state NMR study of amyloid nanocrystals and fibrils formed by the peptide GNNQQNY from yeast prion protein Sup35p.
van der Wel PC; Lewandowski JR; Griffin RG
J Am Chem Soc; 2007 Apr; 129(16):5117-30. PubMed ID: 17397156
[TBL] [Abstract][Full Text] [Related]
27. Refolding and structural characteristic of TRAIL/Apo2L inclusion bodies from different specific growth rates of recombinant Escherichia coli.
Kang H; Sun AY; Shen YL; Wei DZ
Biotechnol Prog; 2007; 23(1):286-92. PubMed ID: 17269700
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of inclusion body formation studied in intact cells by FT-IR spectroscopy.
Ami D; Natalello A; Gatti-Lafranconi P; Lotti M; Doglia SM
FEBS Lett; 2005 Jun; 579(16):3433-6. PubMed ID: 15949804
[TBL] [Abstract][Full Text] [Related]
29. Amyloids in bacterial inclusion bodies.
de Groot NS; Sabate R; Ventura S
Trends Biochem Sci; 2009 Aug; 34(8):408-16. PubMed ID: 19647433
[TBL] [Abstract][Full Text] [Related]
30. Prion and non-prion amyloids of the HET-s prion forming domain.
Sabaté R; Baxa U; Benkemoun L; Sánchez de Groot N; Coulary-Salin B; Maddelein ML; Malato L; Ventura S; Steven AC; Saupe SJ
J Mol Biol; 2007 Jul; 370(4):768-83. PubMed ID: 17532341
[TBL] [Abstract][Full Text] [Related]
31. Identification of a novel cell death-inducing domain reveals that fungal amyloid-controlled programmed cell death is related to necroptosis.
Daskalov A; Habenstein B; Sabaté R; Berbon M; Martinez D; Chaignepain S; Coulary-Salin B; Hofmann K; Loquet A; Saupe SJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(10):2720-5. PubMed ID: 26903619
[TBL] [Abstract][Full Text] [Related]
32. Degradation of fungal prion HET-s(218-289) induces formation of a generic amyloid fold.
Wan W; Wille H; Stöhr J; Baxa U; Prusiner SB; Stubbs G
Biophys J; 2012 May; 102(10):2339-44. PubMed ID: 22677387
[TBL] [Abstract][Full Text] [Related]
33. Signal transduction by a fungal NOD-like receptor based on propagation of a prion amyloid fold.
Daskalov A; Habenstein B; Martinez D; Debets AJ; Sabaté R; Loquet A; Saupe SJ
PLoS Biol; 2015 Feb; 13(2):e1002059. PubMed ID: 25671553
[TBL] [Abstract][Full Text] [Related]
34. The HET-s prion protein of the filamentous fungus Podospora anserina aggregates in vitro into amyloid-like fibrils.
Dos Reis S; Coulary-Salin B; Forge V; Lascu I; Bégueret J; Saupe SJ
J Biol Chem; 2002 Feb; 277(8):5703-6. PubMed ID: 11733532
[TBL] [Abstract][Full Text] [Related]
35. Two structurally similar fungal prions efficiently cross-seed in vivo but form distinct polymers when coexpressed.
Benkemoun L; Ness F; Sabaté R; Ceschin J; Breton A; Clavé C; Saupe SJ
Mol Microbiol; 2011 Dec; 82(6):1392-405. PubMed ID: 22050595
[TBL] [Abstract][Full Text] [Related]
36. Prion protein amyloid formation involves structural rearrangements in the C-terminal domain.
Kumar J; Sreeramulu S; Schmidt TL; Richter C; Vonck J; Heckel A; Glaubitz C; Schwalbe H
Chembiochem; 2010 Jun; 11(9):1208-13. PubMed ID: 20458726
[No Abstract] [Full Text] [Related]
37. Soybean disease resistance protein RHG1-LRR domain expressed, purified and refolded from Escherichia coli inclusion bodies: preparation for a functional analysis.
Afzal AJ; Lightfoot DA
Protein Expr Purif; 2007 Jun; 53(2):346-55. PubMed ID: 17287130
[TBL] [Abstract][Full Text] [Related]
38. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
39. Infectious and noninfectious amyloids of the HET-s(218-289) prion have different NMR spectra.
Wasmer C; Soragni A; Sabaté R; Lange A; Riek R; Meier BH
Angew Chem Int Ed Engl; 2008; 47(31):5839-41. PubMed ID: 18548467
[No Abstract] [Full Text] [Related]
40. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
Cabrita LD; Bottomley SP
Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
